2016
DOI: 10.1073/pnas.1612290113
|View full text |Cite
|
Sign up to set email alerts
|

Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs)

Abstract: Patients with breast cancer often develop malignant regrowth of residual drug-resistant dormant tumor cells years after primary treatment, a process defined as cancer relapse. Deciphering the causal basis of tumor dormancy therefore has obvious therapeutic significance. Because cancer cell behavior is strongly influenced by stromal cells, particularly the mesenchymal stem/stromal cells (MSCs) that are actively recruited into tumor-associated stroma, we assessed the impact of MSCs on breast cancer cell (BCC) do… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

7
137
0
10

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 138 publications
(169 citation statements)
references
References 76 publications
7
137
0
10
Order By: Relevance
“…7 Overall, this might explain why the cannibalistic BCCs in our study recovered their ability to proliferate after just a few days in culture but continued to express SASP factors such as interleukin-1 a (IL1A), C-X-C motif chemokine ligand 8 (CXCL8), CXCL1, C-C motif chemokine ligand 20 (CCL20), and SERPINE1, among other molecules, for at least 5 weeks in vivo. 3 Taken together, our results indicated that BCC cannibalism of BM-MSCs supports certain facets of tumor dormancy (Fig. 1); although a direct causal relationship in patients has been challenging to elucidate as unique MSC markers in vivo are unknown.…”
supporting
confidence: 54%
See 2 more Smart Citations
“…7 Overall, this might explain why the cannibalistic BCCs in our study recovered their ability to proliferate after just a few days in culture but continued to express SASP factors such as interleukin-1 a (IL1A), C-X-C motif chemokine ligand 8 (CXCL8), CXCL1, C-C motif chemokine ligand 20 (CCL20), and SERPINE1, among other molecules, for at least 5 weeks in vivo. 3 Taken together, our results indicated that BCC cannibalism of BM-MSCs supports certain facets of tumor dormancy (Fig. 1); although a direct causal relationship in patients has been challenging to elucidate as unique MSC markers in vivo are unknown.…”
supporting
confidence: 54%
“…3 This conclusion was drawn from compelling data demonstrating that, after consuming BMMSCs, cannibalistic BCCs became highly resistant to stresses imposed by nutrient deprivation and chemotherapy but, strikingly, their ability to form tumors in mice was greatly diminished. 3 In general, cellular cannibalism is a term used to describe a distinct phagocytic-like process in which one cell engulfs and often eliminates neighboring intact cells. 4 Although the phenomenon was first demonstrated over a century ago and has been observed frequently in cancer tissue, 4 its impact on tumor progression has only recently received substantial attention.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Afin d'apprécier les interactions entre des cellules cancéreuses mammaires connues pour être douées d'activités cannibales [5] et des cellules mésenchy-mateuses obtenues à partir du stroma de la moelle osseuse [4], T.J. Bartosh et ses collaborateurs (T exas A&M College of Medicine, Temple, Texas, États-Unis) ont observé, au cours d'expériences de culture cellulaire en trois dimensions, la capacité des cellules mésenchymateuses à interagir avec les cellules cancéreuses, à s'organiser avec ces dernières sous la forme de sphéroïdes et à finalement être « mangées » par les cellules cancéreuses. Lors de ces expériences, les auteurs soulignent la capacité des cellules cancéreuses à internaliser des cellules mésenchymateuses vivantes et à les éliminer selon un processus de mort cellulaire atypique.…”
Section: Les Cellules Cancéreuses Mangent Les Cellules Mésenchymateusunclassified
“…Il a ainsi été proposé que des cellules cancéreuses dont l'activité mitotique est plus faible, les « cellules dormantes », seraient moins sensibles aux thérapies anticancéreuses et pourraient, à la suite de leur « réveil », être à l'origine de l'échappement des tumeurs aux traitements et de la rechute tumorale. Le cannibalisme cellulaire est une nouvelle forme de mort cellulaire au cours de laquelle une cellule vivante « mange » une autre cellule vivante et l'élimine après l'avoir internalisée [2,3] ; ce processus biologique a récemment été identifié comme pouvant conduire à la dormance cellulaire [4].…”
unclassified